We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Salarius Pharmaceuticals announced its lead investigational drug candidate, Seclidemstat, has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for ...
Flex Pharmaceuticals has announced it has entered into a definitive merger agreement with Salarius Pharmaceuticals for an undisclosed sum. The board of directors of both companies have approved the merger.....